Pursuant to a special resolution passed by the shareholders of Devonian Health Group Inc. on March 20, 2025, the company has consolidated its capital on a one-new-for-60-old basis. The name of the company has not been changed.
Effective at the opening of business on Thursday, Jan. 22, 2026, the shares of the company will commence trading on the TSX Venture Exchange on a consolidated basis. The company is classified as a pharmaceutical and medicine manufacturing company (NAICS No. 325410).
Postconsolidation
Capitalization: unlimited shares with no par value, of which
2,765,731 shares are issued and outstanding
Escrow: nil
Transfer agent: TSX Trust Company
Trading symbol: GSD (unchanged)
Cusip No.: 251834 88 3 (new)
© 2026 Canjex Publishing Ltd. All rights reserved.